Effects of glycodiazin and glybenclamide upon insulin secretion in vitro.
D000818:Animals; D003981:Diazoxide / Q000494:pharmacology; D005260:Female; D005947:Glucose / Q000494:pharmacology; D007004:Hypoglycemic Agents / Q000494:pharmacology*; D007093:Imidazoles / Q000494:pharmacology; D066298:In Vitro Techniques; D007328:Insulin / Q000378:metabolism*; D000078790:Insulin Secretion; D010179:Pancreas / Q000187:drug effects*; D011743:Pyrimidines / Q000494:pharmacology*; D051381:Rats; D013451:Sulfonic Acids / Q000494:pharmacology*; D013806:Theophylline / Q000494:pharmacology
D007004:Hypoglycemic Agents; D007093:Imidazoles; D007328:Insulin; D011743:Pyrimidines; D013451:Sulfonic Acids; D013806:Theophylline; D005947:Glucose; D003981:Diazoxide